- Home
- GORV vs BGLC Comparison
GORV vs BGLC Comparison
Compare GORV & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- BGLC
- Stock Information
- Founded
- GORV 1976
- BGLC 2017
- Country
- GORV United States
- BGLC Malaysia
- Employees
- GORV N/A
- BGLC N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- BGLC Medical Specialities
- Sector
- GORV Consumer Discretionary
- BGLC Health Care
- Exchange
- GORV Nasdaq
- BGLC Nasdaq
- Market Cap
- GORV 9.3M
- BGLC 10.4M
- IPO Year
- GORV 2015
- BGLC N/A
- Fundamental
- Price
- GORV $2.36
- BGLC $5.16
- Analyst Decision
- GORV
- BGLC
- Analyst Count
- GORV 0
- BGLC 0
- Target Price
- GORV N/A
- BGLC N/A
- AVG Volume (30 Days)
- GORV 1.6M
- BGLC 103.5K
- Earning Date
- GORV 11-17-2025
- BGLC 11-14-2025
- Dividend Yield
- GORV N/A
- BGLC N/A
- EPS Growth
- GORV N/A
- BGLC N/A
- EPS
- GORV N/A
- BGLC N/A
- Revenue
- GORV $662,952,000.00
- BGLC $9,551,559.00
- Revenue This Year
- GORV $15.65
- BGLC N/A
- Revenue Next Year
- GORV $20.54
- BGLC N/A
- P/E Ratio
- GORV N/A
- BGLC N/A
- Revenue Growth
- GORV N/A
- BGLC 4.01
- 52 Week Low
- GORV $1.83
- BGLC $2.01
- 52 Week High
- GORV $58.80
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- GORV 46.71
- BGLC 46.86
- Support Level
- GORV $1.96
- BGLC $4.69
- Resistance Level
- GORV $2.35
- BGLC $5.65
- Average True Range (ATR)
- GORV 0.34
- BGLC 0.32
- MACD
- GORV 0.03
- BGLC -0.02
- Stochastic Oscillator
- GORV 39.32
- BGLC 48.85
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.